Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mac Kenzie

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Infectious Diseases|February 13, 1999
Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposureT H Roels, A S Bloom, J Buffington, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 9, 2013
Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United StatesD Shepardson, S M Marks, H Chesson, et al.
JAMA|January 23, 1999
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sproutsC A Van Beneden, W E Keene, R A Strang, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 17, 2013
Requirements for the clinical evaluation of new anti-tuberculosis agents in childrenP R Donald, A Ahmed, W J Burman, et al.
MMWR. Morbidity and Mortality Weekly Report|November 12, 2020
Characteristics of Hospitalized COVID-19 Patients Discharged and Experiencing Same-Hospital Readmission - United States, March-August 2020Amy M Lavery, Leigh Ellyn Preston, Jean Y Ko, et al.
Open Forum Infectious Diseases|February 8, 2021
Risk of Clinical Severity by Age and Race/Ethnicity Among Adults Hospitalized for COVID-19-United States, March-September 2020Audrey F Pennington, Lyudmyla Kompaniyets, April D Summers, et al.
The New England Journal of Medicine|August 30, 2018
Bacterial Factors That Predict Relapse after Tuberculosis TherapyRoberto Colangeli, Hannah Jedrey, Soyeon Kim, et al.
Journal of the Pediatric Infectious Diseases Society|December 2, 2015
Rifapentine Pharmacokinetics and Tolerability in Children and Adults Treated Once Weekly With Rifapentine and Isoniazid for Latent Tuberculosis InfectionMarc Weiner, Radojka M Savic, William R Mac Kenzie, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosyJohn S Spencer, Hee Jin Kim, William H Wheat, et al.
JAMA Network Open|June 7, 2021
Underlying Medical Conditions Associated With Severe COVID-19 Illness Among ChildrenLyudmyla Kompaniyets, Nickolas T Agathis, Jennifer M Nelson, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|February 13, 1999
Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposureT H Roels, A S Bloom, J Buffington, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 9, 2013
Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United StatesD Shepardson, S M Marks, H Chesson, et al.
JAMA|January 23, 1999
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sproutsC A Van Beneden, W E Keene, R A Strang, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 17, 2013
Requirements for the clinical evaluation of new anti-tuberculosis agents in childrenP R Donald, A Ahmed, W J Burman, et al.
MMWR. Morbidity and Mortality Weekly Report|November 12, 2020
Characteristics of Hospitalized COVID-19 Patients Discharged and Experiencing Same-Hospital Readmission - United States, March-August 2020Amy M Lavery, Leigh Ellyn Preston, Jean Y Ko, et al.
Open Forum Infectious Diseases|February 8, 2021
Risk of Clinical Severity by Age and Race/Ethnicity Among Adults Hospitalized for COVID-19-United States, March-September 2020Audrey F Pennington, Lyudmyla Kompaniyets, April D Summers, et al.
The New England Journal of Medicine|August 30, 2018
Bacterial Factors That Predict Relapse after Tuberculosis TherapyRoberto Colangeli, Hannah Jedrey, Soyeon Kim, et al.
Journal of the Pediatric Infectious Diseases Society|December 2, 2015
Rifapentine Pharmacokinetics and Tolerability in Children and Adults Treated Once Weekly With Rifapentine and Isoniazid for Latent Tuberculosis InfectionMarc Weiner, Radojka M Savic, William R Mac Kenzie, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosyJohn S Spencer, Hee Jin Kim, William H Wheat, et al.
JAMA Network Open|June 7, 2021
Underlying Medical Conditions Associated With Severe COVID-19 Illness Among ChildrenLyudmyla Kompaniyets, Nickolas T Agathis, Jennifer M Nelson, et al.
Pageof 5